b-tg

BTG 502 is an alkylamide insecticide that binds to voltage-gated sodium channels and reduces sodium currents, antagonising the activation of sodium channels by Batrachotoxin (BTX).

BTG-1640 is used potentially for the treatment of anxiety and panic disorder.

O6BTG-octylglucoside is a potent inhibitor of O6-methylguanine-DNA methyltransferase (MGMT) with IC50 values of 10 nM in HeLa S3 cells and 32 nM in vitro (cell extracts).

NBTGR is a potent nucleoside transport inhibitor(adenosine uptake ,Ki of 70 nM).

O6BTG-C8-αGlu is an O6-methylguanine-DNA methyltransferase (MGMT) inhibitor with an IC50 of 0.45 μM. At a concentration of 0.1 μM, it fully inhibits MGMT in HeLaS3 cells and demonstrates no cytotoxicity even at prolonged high doses (up to 20 μM). This compound is suitable for research on MGMT-related cancers.

BtGH84 Activator I is a BtGH84 activator. It is the small molecule activator of a glycoside hydrolase.

6-Thio-2'-Deoxyguanosine (β-TGdR) is a nucleoside analog and telomerase substrate.

BT-GSI, a γ-secretase inhibitor (GSI) with bone-targeting capabilities, effectively inhibits Notch signaling. Exhibiting dual action, it possesses both anti-myeloma and anti-resorptive properties, making it a promising candidate for research into multiple myeloma and related bone diseases. Additionally, BT-GSI demonstrates potential in inhibiting tumor growth and the progression of osteolytic disease.

MAO-B-IN-45 is a dual inhibitor of ferroptosis and MAO-B. It selectively inhibits MAO-B with an IC50 of 87.47 nM, demonstrating a selectivity over MAO-A by more than 229 times. In vitro, MAO-B-IN-45 exhibits significant anti-ferroptosis activity by modulating iron metabolism pathways and the GSH-GPX4 axis. Additionally, it improves cognitive and behavioral deficits in 3×Tg (APP/Tau/Ps1) Alzheimer's disease mice and significantly reduces levels of ferritin heavy chain 1 (FTH1), β-amyloid protein (APP), and Tau protein phosphorylation (p-Tau) in their brains.